Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer
Crossref DOI link: https://doi.org/10.1136/jitc-2022-005847
Published Online: 2023-01-10
Published Print: 2023-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Karbach, Julia
Kiselicki, Dragan
Brand, Kathrin
Wahle, Claudia
Sinelnikov, Evgueni
Gustavus, Dirk
Hoffmeister, Hans
Prisack, Hans-Bernd
Atmaca, Akin
Jäger, Elke
License valid from 2023-01-10